Keywords: GlaxoSmithKline, Australia, Investment, Manufacturing, Drug development

GlaxoSmithKline injects $60 million into Australian state of Victoria

Article | 06 February 2012

Print This

The Australian subsidiary of UK drug giant GlaxoSmithKline (LSE: GSK) says that it will invest A$60 million ($64.6 million) to expand ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in